Mundipharma

LONDON—Mundipharma International Ltd., the UK-based pharmaceutical firm with ties to the Sackler family of the US, has once again failed to find a buyer for its China operations, despite valuing the unit at over USD 1 billion. The company, known for manufacturing the painkiller OxyContin, has engaged in at least…